Fabio Ynoe de Moraes: The Power of Laser Focus - Lessons from Carlos Alcaraz

Fabio Ynoe de Moraes

Anu Agrawal: The 10th Global Health Catalyst Summit to Advance Global Cancer Collaboration

Anu Agrawal

ESGO President-Elect Jalid Sehouli's Message on World Gynecologic Oncology Day 2025

Jalid Sehouli

More Than $358 Million Invested in Hope, Progress and Cures - Rally Foundation for Childhood Cancer Research

Childhood Cancer

Douglas Flora: The Ultimate Two-Person Performance Review

Douglas Flora

Vincent Rajkumar: Key Takeaways From IMS25

Vincent Rajkumar, IMS25

Top 10 Oncogrants of the Week: Fueling the Next Wave of Cancer Research and Innovation

Top 10 Oncogrants of the Week: Fueling the Next Wave of Cancer Research and Innovation

Robin Zon: ASCO Launches ASCO Edge to Strengthen Practice Management and Patient Care

Robin Zon

OncoCalendar

Loading Events

« All Events

  • This event has passed.

2025 FDA-AACR Workshop: Approach to Novel Oncology Endpoint Development

Sep 11 • 8:00 AM - 3:30 PM
2025 FDA-AACR Workshop

U.S. FDA Oncology Center of Excellence and the American Association for Cancer Research (AACR), will host a one-day hybrid workshop on September 11, 2025, at the Hilton Alexandria Old Town. 2025 FDA-AACR Workshop will address the challenges and opportunities in using novel clinical trial endpoints that can inform regulatory decisions, especially in early-stage and rare cancers where overall survival measurement may be impractical.

Key topics include past successes in endpoint development, evidence requirements to validate novel endpoints, balancing risks and benefits, and leveraging these endpoints within accelerated approval pathways. The workshop will feature case studies and discussions led by experts from regulatory agencies, academia, industry, and patient advocacy.

Venue

Hilton Alexandria Old Town
1767 King St VA 22314 + Google Map